12:00 AM
 | 
Jul 20, 2015
 |  BC Week In Review  |  Company News  |  Deals

amp biosimilars deal

amp granted an undisclosed Chinese pharmaceutical company exclusive, Chinese rights to ABY-018. The humanized mAb is a biosimilar...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >